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Objectives: To identify and quantify inappropriate systemic antibiotic prescribing in primary care in England, and
ultimately to determine the potential for reduction in prescribing of antibiotics.
Methods: Primary care data from 2013–15 recorded in The Health Improvement Network (THIN) database were
used. Potentially inappropriate prescribing events in the database were identified by: (i) comparing prescribing
events against treatment guidelines; (ii) comparing actual proportions of consultations resulting in prescription
for a set of conditions with the ideal proportions derived from expert opinion; and (iii) identifying high prescribers
and their number of prescriptions above an age- and body-system-specific benchmark.
Results: Applying the most conservative assumptions, 8.8% of all systemic antibiotic prescriptions in English pri-
mary care were identified as inappropriate, and in the least conservative scenario 23.1% of prescriptions were
inappropriate. All practices had non-zero reduction potentials, ranging from 6.4% to 43.5% in the middle sce-
nario. The four conditions that contributed most to inappropriate prescribing were sore throat (23.0% of identi-
fied inappropriate prescriptions), cough (22.2%), sinusitis (7.6%) and acute otitis media (5.7%). One-third of all
antibiotic prescriptions lacked an informative diagnostic code.
Conclusions: This work demonstrates (i) the existence of substantial inappropriate antibiotic prescribing and (ii) poor
diagnostic coding in English primary care. All practices (not just the high prescribers) should engage in efforts to
improve antimicrobial stewardship. Better diagnostic coding, more precise prescribing guidelines and a deeper under-
standing of appropriate long-term uses of antibiotics would allow identification of further potential for reductions.
Introduction
The use of antimicrobial drugs puts evolutionary pressure on both
pathogens and commensals, which inevitably results in adapta-
tion through selection of antimicrobial resistance (AMR)1 and rep-
resents a fundamental challenge to public health. There is a direct
link between the magnitude of antimicrobial use and the burden
of AMR,2 suggesting that more prudent antimicrobial use may
decelerate the emergence and subsequent spread of AMR.
Nevertheless, global human consumption of antibiotics has
increased by over a third since 2000,3 despite a mounting consen-
sus that a substantial share of antibiotic use is inappropriate.4–7
Although much of the global rise in human antibiotic consumption
is attributed to developing and transitional countries (where signif-
icant antibiotic under-prescribing and lack of access to healthcare
can also be found), substantial variation within and between
developed countries8–11 is indicative of antibiotic overuse and,
hence, indicative of the potential for safe reductions in antibiotic
prescribing in those counties and regions with comparatively high
levels of use.
In the UK, the Review on Antimicrobial Resistance12 highlighted
the scale and urgency of the AMR threat, prompting the UK Prime
Minister’s pledge of ‘halving the inappropriate prescription of anti-
biotics in humans by 2020’.13 In order to meet this ambition,
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England needed to quantify the extent of inappropriate prescrib-
ing. Although previous work has identified inappropriate prescrib-
ing for selected indications and syndromes in a variety of different
countries,14–17 very few studies have attempted to quantify the
totality of inappropriate antibiotic prescribing (see, for example,
the work by Fleming-Dutra and colleagues on inappropriate pre-
scribing in US ambulatory care5). Furthermore, it is necessary to
quantify the relative contributions of different clinical syndromes
and conditions to the overall level of inappropriate prescribing in
order to allow decision makers and clinicians to prioritize reduction
efforts.
The goal of this paper is to quantify inappropriate prescribing in
English primary care to inform policy in the context of this govern-
ment ambition. Inappropriate prescribing can involve different
types of failings, e.g. prescribing when antibiotic treatment is not
or only marginally beneficial, not prescribing an antibiotic when it
is necessary, or selecting a suboptimal type of antibiotic.18 This
study concentrates exclusively on ‘overprescribing’ and defines
inappropriate prescribing as any antibiotic prescribing that is likely
to have marginal or zero patient benefit and be outweighed by the
potential risks of prescribing.
This paper is part of a series of papers on antibiotic use and
inappropriate prescribing in primary care in England. It synthesizes
the findings of the preceding papers, which: (i) illustrated the cur-
rent use of antibiotics in primary care in England;19 (ii) presented
approaches to define inappropriate prescribing;20 (iii) analysed lev-
els of antibiotic prescribing by condition and variation between
practices;9 and (iv) modelled the influence of comorbidities, steroid
prescriptions and consultation rates on practices’ variation in anti-
biotic prescribing.10 First, guidelines and expert opinion were used
to classify antibiotic prescribing as appropriate or inappropriate;
second, the proportion of inappropriate antibiotic prescriptions in
the period 2013–15 was quantified; and third, variation in inappro-
priate prescribing between practices was analysed.
Materials and methods
Ethics
The Health Improvement Network (THIN) data were used for this work.
The data collection scheme for THIN is approved by the UK Multicentre
Research Ethics Committee (reference number 07H1102103). In accord-
ance with this approval, the study protocol was reviewed and approved by
an independent Scientific Review Committee (reference numbers
16THIN071 and 16THIN071-A1).
Data
Data were obtained from THIN, a primary care electronic database that
contains anonymized patient, prescribing practice, and consultation data
(for details see Dolk et al.19). Systemic antibiotic prescriptions, except antitu-
berculosis and antileprosy drugs, recorded during the years 2013–15 were
extracted for all participating English practices that met minimal data qual-
ity criteria (see below). These prescriptions were the totality against which
reduction potentials were determined.
Practices were excluded from analyses if less than half of their antibiotic
prescriptions could be linked with one or more informative diagnostic code(s)
(prescription–diagnosis linkage is described in detail in Dolk et al.19), i.e. those
practices that generally fail to document the clinical indications underlying
their prescriptions. Further, practices were excluded if they were in the lowest
decile of annual consultation rates for more than one (out of 11) conditions
included in the expert elicitation,20 i.e. those with atypically low consultation
rates for common conditions (suggesting poor coding habits). Finally, practi-
ces were excluded if they had not been contributing to THIN for at least one
full year during the study period. Comparisons between included and
excluded practices were performed. Of note, inclusion and exclusion criteria
for practices and prescriptions differed between the papers in this
Supplement9,10,19,20 and so some results, such as the proportion of prescrip-
tions without a linked diagnostic code, will also differ.
Approach for classifying appropriateness
The appropriateness of antibiotic prescriptions was determined in a
three-step approach. First, prescriptions with a diagnostic code were com-
pared against treatment guidelines.20 Then, estimates from an expert
elicitation20 were used to determine appropriateness of additional prescrip-
tions that could not be classified as appropriate or inappropriate using
guidelines alone. Finally, for prescriptions covered neither by guidelines nor
by the expert elicitation, distributions of prescribing proportions and rates
were used to identify practices with very high prescribing and to flag their
‘excess prescribing’ as potentially inappropriate.
If a prescription was linked with multiple diagnostic codes that (poten-
tially) justify antibiotic prescribing, the diagnostic code most likely to war-
rant antibiotic prescribing was assumed to underlie the prescription.
Guideline-based classification
Diagnostic codes linked with antibiotic prescriptions19 were compared with
infection treatment guidance/guidelines issued by PHE, NICE and professio-
nal societies.20 For some codes, guidelines unambiguously indicate
whether the use of antibiotics is clearly appropriate (prescribing is always
warranted or necessary) or clearly inappropriate (prescribing is never indi-
cated). For many codes, however, guidelines indicate that antibiotics should
only be prescribed in certain circumstances [e.g. for upper respiratory tract
infection (URTI), antibiotic prescribing is only warranted in the event of spe-
cific combinations of symptoms and/or a severe clinical presentation].
Since severity markers and combinations of symptoms were mostly
unavailable in the THIN dataset, using guidelines to reliably classify these
prescriptions was not possible. Finally, in many cases diagnostic codes were
missing, or the codes described conditions for which no English guidelines
exist. Here, any judgement on appropriateness based on guidelines was
not possible, with the exception of nitrofurantoin being prescribed to men
in the absence of a diagnostic code, because nitrofurantoin is only used to
treat urinary tract infection (UTI) and antibiotics should always be pre-
scribed to treat male UTI.21
Expert-based classification
For a defined list of common conditions that may or may not require antibi-
otic treatment depending on other factors, an expert elicitation was con-
ducted to generate probability distributions of ‘ideal’ antibiotic prescribing
proportions, i.e. the proportions of patients that should be prescribed sys-
temic antibiotics when presenting to primary care with a given condition
(described in detail elsewhere20). For each of these conditions, all consulta-
tions were extracted for which patient characteristics matched the case
description of the elicitation question. Some questions excluded comorbid-
ities or focused on a specific age group or gender, e.g. UTI is more frequent
but typically less complicated in women; treatment guidelines for acute oti-
tis media (AOM) are different for young children (described in detail
elsewhere9). The main rationale for exclusions was to focus on seemingly
uncomplicated presentations of conditions, with the exception of acute
exacerbations of COPD and to separate demographic groups for which
treatment guidelines differ.
The proportion of consultations that resulted in a systemic antibiotic
prescription was calculated for these conditions in each practice included in
the analysis. Practice- and condition-specific prescribing proportions were
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then compared with ideal prescribing proportions derived from the distribu-
tions of the pooled expert opinions.9,20 Different quantiles of these distribu-
tions were used as benchmarks of appropriate prescribing in different
scenario analyses (see below). If the measured prescribing proportion of a
practice was below the estimate of ideal prescribing for a specific condition,
all prescriptions for that condition were deemed appropriate. Conversely, if
a practice’s prescribing proportion was higher than the expert estimate,
then all excess prescribing, i.e. the proportion of all prescriptions above the
ideal prescribing benchmark, was deemed inappropriate.
Distribution-based classification
A large proportion of prescriptions were not classifiable based on either
guidelines or expert opinion, partly due to poor coding. Therefore, differen-
ces in prescribing behaviour between practices were used as an additional
means by which to identify more cases of suspected overprescribing.
All prescriptions that were not covered by either guidelines or expert opinion
were stratified by age group (,18, 18–65, .65 years) and body system
according to diagnostic code [respiratory tract infection (RTI) including ear,
nose and throat (ENT); urogenital; skin and wounds; gastrointestinal; mis-
cellaneous]. For each of these groups, all respective consultations were
extracted from THIN to establish age group-specific prescribing proportions
for these body systems. Age group-specific prescribing rates per practice
were also established for prescriptions without a diagnostic code.
Then, different quantiles were determined for all groups as benchmarks,
based on practice variation in prescribing (see below). If a practice was pre-
scribing more antibiotics than given by these distribution-based bench-
marks, then its excess prescribing was marked as inappropriate. This
approach allowed quantification of the contribution of high prescribers to
inappropriate prescribing.
Scenario construction
Both the expert- and distribution-based classifications require assumptions
about the ‘correct’ threshold that separates appropriate from inappropriate
prescribing. Experts’ uncertainty regarding their estimates of ideal prescrib-
ing was measured and the distributions of each expert were pooled to gen-
erate average estimates, but no value-free and objectively correct
benchmark can be derived from these distributions. The same is true for the
benchmarks derived from between-practice variation used in the
distribution-based classification, for which no data exist to objectively
inform a decision on where overprescribing begins and appropriateness
ends.
Three different scenarios will be presented to capture a reasonable
range of possible assumptions for these classification approaches.
The most conservative scenario uses the third quartile of pooled expert esti-
mates (i.e. the ‘most generous’ estimates of antibiotic appropriateness
from the experts) as benchmarks for the expert-based classification and no
distribution-based classification is used; the middle scenario uses the
median of the expert-based classification and the third quartile of
distribution-based classification (i.e. only the highest 25% of prescribers
would be considered to be overprescribing in the distribution-based classifi-
cation); and the least conservative scenario uses the first quartile of expert-
based classification (i.e. the ‘strictest’ end of the expert opinion distribution)
and the median of the distribution-based classification such that
those practices prescribing above the median were considered to be
overprescribing.
Condition- and practice-level analyses
The main analyses present proportions of inappropriate and appropriate
prescriptions at an aggregate level (i.e. proportions of all prescriptions of all
English practices included in the analyses). In addition to these aggregate
analyses, contributions of individual conditions to the overall proportion of
inappropriate prescriptions are highlighted. Finally, scatter plots relate each
included practice’s antibiotic prescribing rate to their identified (i) proportion
and (ii) rate of inappropriate prescriptions.
Results
Included versus excluded practices
The inclusion criteria were met by 260 out of 349 (74.5%) English
practices that contributed to THIN in the study period. The included
practices issued 3740186 prescriptions (81.8%; all practices:
4574373).
The following comparisons between included and excluded
practices are based on the year 2013.
Excluded practices tended to be smaller than included practi-
ces, with a median of 6943 (IQR 4498–11698) registered patients
(mid-year) versus 10853 (IQR 7476–15221) registered patients.
Excluded and included practices had similar prescribing rate
distributions with medians of 48.5 per 100 practice population
(excluded; IQR 39.6–57.3) and 52.8 (included; IQR 45.7–62.3)
respectively. Also the trimethoprim to trimethoprim and nitrofur-
antoin ratio and the co-amoxiclav to co-amoxiclav and amoxicillin
ratio—both indicators for good prescribing practice as both
the ratios should be low—were similar between excluded
and included practices. Medians for trimethoprim were 0.70
(IQR 0.60–0.74) in excluded and 0.67 (IQR 0.59–0.73) in included
practices. For co-amoxiclav, medians were 0.15 (IQR 0.10–0.21) in
excluded and 0.15 (IQR 0.10–0.21) in included practices.
Coverage (guideline- and expert-based)
Only 22.6% of all prescriptions could be classified as appropriate or
inappropriate: 6.4% were classified based on treatment guidelines
and 16.2% were prescriptions for conditions included in the expert
elicitation. An additional 33.2% of prescriptions were covered by
guidelines, but appropriateness could not be determined because
(i) appropriateness depended on often unavailable patient-specific
information (e.g. symptom severity) and (ii) they were not included
in the expert elicitation. Conditions not covered by guidelines and
not included in the expert elicitation accounted for 11.0% of pre-
scriptions and 33.2% of all prescriptions were not documented
well enough to determine appropriateness, i.e. they had either no
or only non-specific diagnostic codes. These figures differ slightly
from those reported previously,20 because here some practices
were excluded based on the quality of their coding.
Proportions of appropriate and
inappropriate prescriptions
Using the medians of pooled expert opinions20 as benchmarks for
ideal prescribing proportions9 (as in the middle scenario) in combi-
nation with guidelines, 11.3% of all prescriptions were found to be
inappropriate and 11.3% were found to be appropriate (Figure 1).
The remaining 77.4% could not be directly classified based on
guidelines or expert opinion. For the prescriptions that could not be
directly classified as either appropriate or inappropriate, the
distribution-based approach was used to identify excess
prescribing.
Combining all three classification approaches (i.e. guideline-,
expert- and distribution-based), in the least conservative scenario
23.1% of all prescriptions were classified as inappropriate, in the
Smieszek et al.
ii38
D
ow
nloaded from
 https://academ
ic.oup.com
/jac/article-abstract/73/suppl_2/ii36/4841818 by St G
eorge's U
niversity of London user on 13 N
ovem
ber 2018
middle scenario 15.4%, and in the most conservative scenario
8.8% (Figure 2).
Contributions by condition
In the middle scenario, the conditions that contributed most to
inappropriate prescribing were sore throat (23.0% of all identified
inappropriate prescriptions), cough (22.2%), sinusitis (7.6%), AOM
in patients older than 6 months and younger than 18 years (5.7%),
urinary tract infections (3.4%), acne (2.1%), impetigo (1.8%), and
bronchitis (1.6%). In total, in the middle scenario, more than 60%
of all identified inappropriate prescriptions were related to RTI and
ENT conditions. In the other scenarios, the relative importance of
some conditions shifted, but the ranking of the four most influen-
tial conditions remained the same.
Variation in inappropriate prescribing
between practices
Practices varied in the proportions of their prescriptions that were
determined to be inappropriate. All practices had a non-zero pro-
portion of inappropriate prescriptions. In the least conservative
scenario, inappropriate proportions of individual practices’ pre-
scribing ranged from 9.5% to 52.9%, in the middle scenario from
6.4% to 43.5%, and in the most conservative scenario from 3.6%
to 16.9%.
Figure 3 shows the proportion (Figure 3a) and the rate
(Figure 3b) of inappropriate prescriptions by practice, based on
guidelines and expert opinion (median values) only. No relation-
ship between practices’ antibiotic prescribing rates and their pro-
portions of inappropriate prescriptions was found (Figure 3a),
when only considering inappropriateness based on guidelines and
expert opinion (excess prescribing identified with the distribution-
based approach is, by definition, dependent on the quantity of
prescribing, since we defined excess prescribing as the prescribing
of practices above a pre-defined threshold; compare with
the Distribution-based classification section in Materials and
methods).
Discussion
In all scenarios, inappropriate prescribing in English primary care
could be identified, ranging from 8.8% to 23.0% of all prescriptions,
while 33.2% of all prescriptions were without an informative diag-
nostic code and, hence, could not be assessed regarding their
appropriateness. Furthermore, inappropriate prescribing was iden-
tified in all included practices, ranging from 3.6% of a practice’s
prescriptions (minimum of most conservative scenario) to 52.9%
(maximum of least conservative scenario). The conditions that
contributed the most to inappropriate prescribing were sore throat,
cough, sinusitis and otitis media.
Strengths and limitations
To our knowledge, this is the first attempt to quantify inappropriate
prescribing in English primary care, and, globally, is one of only a
few attempts to quantify inappropriate prescribing at the national
level.
Using guidelines and expert opinion, only a relatively small per-
centage (22.6%) of all prescriptions could be classified as either
appropriate or inappropriate, although this value includes the con-
ditions that are believed to contribute most to inappropriate pre-
scribing. In particular, RTI consultations—many of which are
covered in our work via guidelines and expert opinion—have
repeatedly been proposed as main drivers of overprescribing since
RTIs constitute a dominant part of all prescriptions,19 and, particu-
larly in the case of URTI, only rarely warrant antibiotic use.20,22
Nonetheless, a substantial proportion of inappropriate prescribing
could not be identified by our approach, in particular because of
poor coding and because the expert elicitation was limited to a
subset of common conditions and excluded complicated presen-
tations. While potential inappropriate prescribing among unidenti-
fied prescriptions is covered by the distribution-based approach (in
the middle and least conservative scenarios), this approach is not
mechanistic and, hence, thresholds have been set relatively con-
servatively. Therefore, it is likely that the amount of inappropriate
prescribing has been substantially underestimated for conditions
Inappropriate (guidelines)
11.3% 77.4% 11.3%
33.2% 44.2%
Appropriate (guidelines)
Appropriate (expert opinion)Inappropriate (expert opinion)
Not understood regarding appropriateness
Informative diagnostic code
No/no informative diagnostic code
Figure 1. Proportions of appropriate, inappropriate and indeterminate systemic antibiotic prescriptions as identified using treatment guidelines and
expert opinion (medians of experts’ pooled distribution).
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Figure 3. Prescribing rates of English practices versus their inappropriate prescribing [based on guidelines and expert opinion (medians) only].
(a) Inappropriate prescribing as a percentage of the totality of a practice’s prescriptions. (b) Inappropriate prescriptions per practice population (mid-
year). Dot colours: purple, practices in the highest inappropriate prescribing quartile; cyan, practices between median and third quartile; green, practi-
ces between first quartile and median; red, lowest quartile.
0.8
8.8%
11.3%
13.3% 9.8%
12.5 4.6 5.2
4.1%
0.8
0.8
0% 25% 50%
All antibiotic prescribing
Guidelines
Expert opinion
Prescribing proportions
Prescribing rates
Appropriateness undetermined
Appropriate Inappropriate
75% 100%
1.8 2.3
Most conservative scenario
Middle scenario
Least conservative scenario
8.0
10.5 31.0
28.1 39.5 3.8 5.6
42.2 5.7 5.6
77.3 8.2 5.6
Figure 2. Proportions of inappropriate and appropriate antibiotic prescription in three scenarios: most conservative, middle and least conservative.
Appropriateness was determined using treatment guidelines, expert opinion of ideal prescribing proportions for defined conditions, and by identifying
‘excess’ prescribing based on unusually high prescribing proportions and rates.
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not included in the expert elicitation and not unambiguously cov-
ered by guidelines.
One quarter of practices had to be excluded from the analysis
for data quality reasons and the data quality of the included practi-
ces is not ideal. While excluding practices could, in principle, intro-
duce bias, we found that excluded and included practices were
reasonably similar regarding three different indicators for antibi-
otic prescribing quantity and quality (antibiotic prescribing rate,
trimethoprim to trimethoprim and nitrofurantoin ratio and co-
amoxiclav to co-amoxiclav and amoxicillin ratio). So we believe the
analysed sample is representative. Deficient coding in the included
practices could also have resulted in an underestimation of the
denominators of the prescribing proportions (e.g. if prescribers
were more likely to enter a diagnostic code when prescribing). As a
result, the fraction of inappropriate prescriptions would have been
overestimated. However, as discussed elsewhere,9 the very low
prescribing proportions found for some conditions indicate that
such a bias, if it exists, is unlikely to have been substantial.
Antibiotic prescribing is not equal to antibiotic consumption
because patients do not always fill a prescription and dispensed
antibiotics are not always used for the current illness (but may
be kept and used for self-medication during another period of
illness23). One reason for the difference between antibiotic pre-
scribing and consumption is delayed (or ‘back-up’) prescribing, a
strategy whereby prescribers issue an antibiotic prescription but
advise the patient only to fill the prescription and use the antibiotic
if symptoms worsen or fail to resolve within a certain period of
time. Delayed prescribing has been proven to reduce antibiotic
consumption, but its capacity to reduce consumption varies
depending on the specific condition, how it is implemented and
other factors.24 There are codes in THIN for delayed prescribing,
but prescribers use them very rarely (1.5& of prescriptions) and,
hence, it was not possible to estimate the magnitude of delayed
prescribing in this setting (previous work found that delayed
prescribing was used in 14% of acute sore throat consultations25
and in 13.3% of uncomplicated lower RTI consultations26).
Furthermore, it is still unclear how successful delayed prescribing is
in reducing antibiotic dispensing.27 As a consequence, some pro-
portion of prescriptions that were earmarked as inappropriate may
have been delayed prescriptions that were never dispensed or
consumed.
This work concentrated on the identification of inappropriate
prescribing events among acute and seemingly uncomplicated
presentations of a selection of RTIs, UTIs and skin conditions.20
Antibiotic appropriateness in more complex cases, such as in
patients receiving repeat prescriptions or having (sometimes mul-
tiple) comorbidities, is very difficult to assess, in part because treat-
ment decisions are influenced by a multitude of patient factors
that are poorly captured in THIN. Nevertheless, previous work has
shown that a substantial fraction of antibiotics are used in patients
who receive antibiotics repeatedly and/or over long periods of
time,19,28 and a substantial fraction of complex patients are likely
to receive inappropriate prescriptions.28 While reducing unneces-
sary prescriptions in uncomplicated presentations of, in particular,
RTI can be seen as ‘low-hanging fruit’ in terms of reducing antibi-
otic prescribing, there will be further potential for reductions in
patients with comorbidities and in long-term use of antibiotics that
could not be assessed in this work.
Our working definition of inappropriateness was limited to
unnecessary antibiotic prescriptions. There are other forms of inap-
propriate prescribing, including inappropriate choice of antibiotic
(when prescribing is warranted), inappropriate duration or dose of
antibiotic treatment, and the decision not to prescribe when an
antibiotic would have been indicated. To avoid the development
and spread of AMR, completely avoiding unnecessary antibiotic
prescriptions in primary care seems to be the most promising initial
strategy. Nonetheless, avoiding suboptimal drug choice, dosage or
duration when antibiotic treatment is warranted will also help to
decelerate the spread of AMR and mitigate adverse outcomes due
to treatment failure. At the same time, minimizing the number of
inappropriately withheld treatments is crucial for patient safety
and wellbeing (however, in developed countries such as England,
under-prescribing can be expected to be a relatively rare event29).
While we have prioritized identifying unnecessary prescriptions, it
will be important to comprehensively study the other aspects of
inappropriate prescribing, too.
Implication for reducing inappropriate prescribing
Any target for reducing inappropriate prescribing in England will
need to evolve as (i) better primary care data and more precise
guidelines will allow identification of more inappropriate prescrib-
ing events; (ii) better diagnostic and prognostic tools help general
practitioners and nurses to better distinguish bacterial infections
and poor-prognosis illnesses that require antibiotic treatment
from other cases;30–32 and (iii) the incidence of bacterial infections
as well as the prevalence of relevant comorbidities might change
over time.33–35
The UK is in the lower half of European countries with respect to
outpatient antibiotic use.36 Nonetheless, the levels of prescribing
of English practices are high across the board when compared
with low-prescribing countries. Furthermore, even low-prescribing
countries such as Sweden and the Netherlands have recently iden-
tified reduction potentials and are aiming to further reduce pre-
scribing of antibiotics in primary care.37–39 We found a non-zero
proportion of inappropriate prescribing for all practices included in
our analysis and, hence, almost all practices in England will have
the potential to reduce antibiotic prescribing without withholding
prescriptions to patients who truly need antibiotic therapy.
One would expect high-prescribing practices to have higher
proportions of inappropriate prescriptions. This was not found in
our analyses. While, obviously, absolute numbers of inappropriate
prescriptions were higher in high-prescribing practices than in low-
prescribing ones (Figure 3b), no association between prescribing
rate and relative numbers could be found. This deviation from the
expected may have multiple explanations. For example, high pre-
scribers might document symptoms and diagnoses less frequently
than low prescribers (a slight positive correlation between prescrib-
ing rate and proportion of prescriptions without informative diag-
nostic code was found; results not shown) and, hence, a larger
fraction of their inappropriate prescribing might be hidden among
prescriptions without useful diagnostic codes. Further, previous
work has found an association between consultation and anti-
biotic prescribing rates10 and it has been suggested that gener-
ous antibiotic prescribing might encourage patients to consult
more often (for, in principle, self-limiting conditions).40–42 As a
result, high prescribers might see relatively milder presentations of
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certain infections and should, ideally, prescribe to a lower propor-
tion of consultations than low-prescribing practices. This work has
not been able to prove that high prescribers have relatively more
potential for safe reduction of antibiotic prescribing, even though
this seems likely (compare with work presented in this Supplement
that found that comorbidities do not explain much of the variation
in practice-level prescribing10).
Finally, we were able to identify conditions and syndromes for
which a large volume of inappropriate prescriptions was issued.
This allows practitioners and policy makers to prioritize their efforts
in trying to reduce unnecessary prescribing. A particular focus
should be on prescriptions for sore throat, cough and sinusitis.
Conclusions
This work has shown there is potential for reduction in inappropriate
antibiotic prescribing of between 8.8% and 23.0% of all prescrip-
tions (relative to 2013–15) in English primary care, depending on
which assumptions were made. The real reduction potential is prob-
ably higher and it is important to note that the totality of inappropri-
ate prescribing is a moving target that may change with better
data, new scientific insights and novel diagnostic tools becoming
available. All practices included in the analyses had some potential
to reduce their antibiotic prescribing, which suggests that currently
all English practices can be expected to reduce antibiotic prescribing
(without withholding appropriate and necessary prescriptions).
For improving future assessment of antibiotic prescribing in primary
care, substantially improved documentation of diagnoses and
severity is vital. For the period 2013–15, one-third of all prescriptions
completely lacked diagnostic information. Immediate versus
delayed prescribing should also be clearly distinguished in data.
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